KKRKKRFinancial Services · Asset Management

KKR Stock Forecast: KKR & Co., Inc. Price Predictions for 2026-2027

Last close, 17 Sept 2026
$98
+1.39% on the day

The 22 Wall Street analysts covering KKR & Co., Inc. hold a median 12-month price target of $126 — +28.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 17 Sept 2026 — in the upper half.

Market cap
$89.4B
Ticker Nerd rank
62 / 100
Median analyst target
$126
Analysts covering
22
Revenue$5.7B+13.1% y/y
Operating income$325.7M
Net income$1.1B
Free cash flow$3.2B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−2.7%
1M
−9.8%
YTD
−22.5%
1Y
−31.5%
From 52W high
−33.8%
From 52W low
+17.5%
$84
$148
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

KKR stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores KKR & Co., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Sept 2026
62 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
92
Revisions
91
Value
80
Volatility
73
Quality
64
Issuance
44
Momentum
29
Accruals
22
Size
3

Growth (92): Sales and profits are climbing, and climbing faster than before.

Accruals (22): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

KKR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on KKR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$80$100$120$140$160$180Oct 25Jan 26Apr 26Jul 26KKRHigh $166Median $126Low $115

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says22 analysts
19 Buy3 Hold0 Sell
Low $115Median $126High $166

The green dot is the last close — the median target sits +28.3% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 7 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
27 Aug 2026OppenheimerMaintainsOutperform$139$166
4 Aug 2026Argus ResearchMaintainsBuy
4 Aug 2026Argus ResearchMaintainsBuy$115$125
3 Aug 2026BMO CapitalMaintainsOutperform$112$118
3 Aug 2026BMO CapitalMaintainsOutperform
3 Aug 2026TD CowenMaintainsHold$108$111
3 Aug 2026TD CowenMaintainsHold
31 July 2026BarclaysMaintainsOverweight
31 July 2026BarclaysMaintainsOverweight$124$135
31 July 2026RBC CapitalMaintainsOutperform
31 July 2026RBC CapitalMaintainsOutperform$125$134
21 July 2026Morgan StanleyMaintainsOverweight
21 July 2026Morgan StanleyMaintainsOverweight$153$147
20 July 2026HSBCMaintainsBuy$118$121
20 July 2026HSBCMaintainsBuy
17 July 2026OppenheimerMaintainsOutperform
17 July 2026OppenheimerMaintainsOutperform$143$139
13 July 2026BMO CapitalMaintainsOutperform$120$112
13 July 2026BMO CapitalMaintainsOutperform
13 July 2026Evercore ISI GroupMaintainsOutperform

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. KKR appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

KKR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 17 Sept 2026, KKR & Co., Inc. returned −31.5% against +17.0% for the S&P 500, dividends included.

KKR vs S&P 500, last 12 monthsTotal return, rebased to 100
60708090100110120Oct 25Jan 26Apr 26Jul 26KKRS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

KKR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+4.7%
Analysts raising
16
Analysts cutting
1
Fundamentals

KKR & Co., Inc. (KKR) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
30.9×

Cheaper than 24% of US stocks

Price / sales
3.5×

Cheaper than 36% of US stocks

Price / book
3.1×

Cheaper than 32% of US stocks

EV / EBITDA
35.1×

Cheaper than 7% of US stocks

Growth & margins
Revenue growth (YoY)
7.8%

Higher than 46% of US stocks

Earnings growth (YoY)
37.3%

Higher than 70% of US stocks

Gross margin
18.9%

Higher than 20% of US stocks

Operating margin
20.6%

Higher than 80% of US stocks

Net margin
12.2%

Higher than 74% of US stocks

Returns & dividend
Return on equity
7.3%

Higher than 57% of US stocks

Return on assets
1.4%

Higher than 54% of US stocks

Dividend yield
0.8%

Higher than 16% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

KKR & Co., Inc. (KKR) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • KKR & Co., Inc. has a market value of $89.4B and an enterprise value of $147.5B.

  • Revenue in the twelve months to 30 June 2026: $21.1B. The latest quarter grew 7.8% year on year.

  • Net income over the same four quarters: $5.5B, a 26.2% net margin.

  • Diluted earnings per share, trailing twelve months: $3.14.

  • Free cash flow in the twelve months to 30 June 2026: $2.3B.

  • KKR & Co., Inc. spent $233.2M on share buybacks and $831.3M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 897.8M.

  • Trailing P/E: 30.9×; forward P/E: 13.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.79%, paying out 24% of earnings.

  • KKR & Co., Inc. employs 5,043 people $4.2M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 17 Sept 2026

Data provided by Twelve Data

Peers

KKR vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelAsset Management
CompanyMarket capTKN rank
KKRKKR & Co., Inc.$89.4B
62
BNBrookfield Corp.$83.0B
44
BAMBrookfield Asset Management Ltd.$74.5B
40
APOApollo Global Management, Inc.$73.1B
45
STTState Street Corp.$51.0B
92
AMPAmeriprise Financial, Inc.$50.7B
93
BXBlackstone, Inc.$154.1B
50

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own KKR & Co., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest KKR news & analysis

The Fed's never been so confident on economic growth. What investors should do now, according to KKR.

Market Watch · 18 Sept 2026positive

According to Market Watch, KKR commented on the Federal Reserve's economic outlook, noting that members of the Federal Open Market Committee showed their lowest level of worry about GDP growth since the Fed first began releasing its outlook. The report frames this as the Fed's strongest confidence in economic growth on record.

Why it matters — A KKR watcher would care because the firm is offering its read on Fed confidence in economic growth, which can influence investment conditions and market sentiment relevant to KKR's activities.

5 Cheap REITs With Dividends Above 3% to Buy on the Dip

Zacks Investment Research · 18 Sept 2026neutral

Zacks highlighted five real estate investment trusts (REITs) with dividend yields above 3% as potential buy-the-dip opportunities if higher interest rates trigger another selloff in the sector. The report focuses on these cheap real estate stocks as attractively valued income plays.

Why it matters — KKR, which has substantial real estate investment exposure, would be affected by the broader REIT market dynamics that higher interest rates and sector selloffs could create.

Top 4 Stocks to Buy Now Regardless of Fed Rate Hikes, According to InfraCap Investment Chief Jay Hatfield

Benzinga · 16 Sept 2026positive

Infrastructure Capital Advisors CEO and CIO Jay Hatfield, in a conversation with Phil Rosen, highlighted four stocks he believes can perform well regardless of the Federal Reserve's interest-rate policy decision. The four stocks are among those recommended by Hatfield in the interview.

Why it matters — A KKR watcher would care because, if KKR is among the stocks Jay Hatfield highlighted, the endorsement signals that the firm may perform well despite Federal Reserve rate hikes.

KKR & Co. Inc. (KKR) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Seeking Alpha · 15 Sept 2026neutral

KKR & Co. Inc. presented at the Barclays 24th Annual Global Financial Services Conference. A transcript of the presentation was published, detailing the company's remarks at the event.

Why it matters — The conference presentation gives KKR watchers direct insight into the firm's current positioning and strategic commentary as communicated to the financial services community.

Neuberger and KKR to Invest in Datavant Alongside New Mountain Capital

Business Wire · 15 Sept 2026positive

Datavant, a healthcare data collaboration platform, announced that funds managed by Neuberger Capital Solutions and Neuberger Private Markets, along with investment funds managed by KKR, have agreed to acquire a significant minority stake in the company. New Mountain Capital, an investor in Datavant since 2014, will retain its investment.

Why it matters — This deal expands KKR's holdings in the healthcare data and technology sector through a minority investment in Datavant alongside other major investors.

FAQ

Frequently asked questions about KKR stock

What is the KKR stock price forecast for 2026-2027?

The 22 Wall Street analysts covering KKR & Co., Inc. have a median 12-month price target of $126, with estimates ranging from $115 to $166. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is KKR stock a buy right now?

Of the 22 analysts covering KKR & Co., Inc., 19 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks KKR & Co., Inc. 62 out of 100 across roughly 4,600 US stocks as at 17 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank KKR?

As at 17 Sept 2026, KKR & Co., Inc. ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (92 of 100).

Will KKR stock go up?

No one can know that. What the data says: the median 12-month target from 22 analysts implies +28.3% from the last close, and Ticker Nerd's factor model ranks KKR & Co., Inc. 62 out of 100 as at 17 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the KKR stock forecast for 2030?

No analyst covering KKR & Co., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KKR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $115 to $166 over the next 12 months.

How has KKR stock performed over the past year?

KKR & Co., Inc. returned -31.5% over the 12 months to 17 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does KKR & Co., Inc. do?

Korro Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines for rare and more common diseases.

What is the latest news on KKR?

The most recent item we track (Market Watch, 18 Sept 2026): "The Fed's never been so confident on economic growth. What investors should do now, according to KKR.". According to Market Watch, KKR commented on the Federal Reserve's economic outlook, noting that members of the Federal Open Market Committee showed their lowest level of worry about GDP growth since the Fed first began releasing its outlook. The report frames this as the Fed's strongest confidence in economic growth on record.

Company

About KKR & Co., Inc.

Korro Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines for rare and more common diseases. The company’s programs are designed to make precise changes at the RNA level, aiming to address disease-causing biology without permanently altering DNA. Its current pipeline includes lead candidate KRRO-121, a GalNAc-conjugated RNA editing oligonucleotide under development for hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy, along with additional research programs in liver and other therapeutic areas. Korro Bio’s platform is built around programmable RNA editing and oligonucleotide-based delivery, positioning the company within the growing field of next-generation genetic medicines. Based in Cambridge, Massachusetts, Korro Bio focuses on discovery and development activities across its research and clinical-stage portfolio.

CEO Mr. Joseph Y. Bae · 5,043 employees · United States · https://www.kkr.com